USE OF DRUGS IN THE TREATMENT OF OBESITY

Authors
Citation
Rl. Atkinson, USE OF DRUGS IN THE TREATMENT OF OBESITY, Annual review of nutrition, 17, 1997, pp. 383-403
Citations number
76
Categorie Soggetti
Nutrition & Dietetics
Journal title
ISSN journal
01999885
Volume
17
Year of publication
1997
Pages
383 - 403
Database
ISI
SICI code
0199-9885(1997)17:<383:UODITT>2.0.ZU;2-X
Abstract
Obesity has become an epidemic in the United States and in many other countries of the world. Obesity is a chronic disease, not a failure of willpower. Diet, exercise, and behavioral modification of lifestyle a re rarely successful over the long term. Medications have been used sp aringly, because of concerns about addiction and ineffectiveness, but used chronically, obesity drugs are effective. The two main categories of obesity drugs are centrally active adrenergic and serotonergic age nts. These drugs reduce appetite, enhance satiety, and increase energy expenditure. Use of single agents produces modest weight loss and use of combinations increases loss, but few patients reach their goal wei ght. Co-morbidities associated with obesity resolve or are reduced in severity with weight loss. Adverse events of major concern are changes in brain biochemistry and primary pulmonary hypertension. Published g uidelines for use of obesity medications recommend they be used only f or medically significant obesity.